DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR MS Speaks
       *****************************************************
   DIR 22 cases if listeriosis (3 of them fatal) linked to Lemtrada i...
       0 replies
   DIR (ECTRIMS) Lemtrada more effective than competing MS treatments
       1 replies
   DIR Severe B-cell-mediated CNS disease secondary to alemtuzumab 
       1 replies
   DIR (Abst.) Alemtuzumab beats Rebif for RRMS in MRI endpoints
       0 replies
   DIR (AAN) 10-year follow-up data on Lemtrada
       0 replies
   DIR (AAN) Alemtuzumab's immunosuppressive effect doesn't last more...
       0 replies
   DIR (Abst.) Cochrane Database Review of alemtuzumab
       0 replies
   DIR (Abst.) Alemtuzumab for MS: Long-term follow-up in multi-cente...
       0 replies
   DIR (ECTRIMS abst.) Long-term follow-up of early cohorts (alemtuzu...
       0 replies
   DIR Allegheny General Hospital (PA) offering Lemtrada as MS treatm...
       0 replies
       *****************************************************
   DIR Previous Page
   DIR Next Page